CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Data incorporated for this study were collected from 9 centers in the UK focused on third-line and beyond chimeric antigen receptor (CAR) T-cell administration in patients with relapsed/refractory ...

Only few early customers will receive cars for purpose of testing in real-world controlled environment ensuring compliance SANTA MATEO, Calif., Dec. 9, 2025 /PRNewswire/ -- Alef Aeronautics, a ...